By Douglas Feil, NBCF Chief Program Officer The burgeoning popularity of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, widely...
HUNTSVILLE, AL — In the rapidly shifting landscape of modern oncology, the distance between a high-tech laboratory...
NEW YORK CITY — On a Tuesday that bridged the gap between the morning commute and a...
OTTAWA – As the landscape of oncology shifts toward increasingly personalized medicine, a comprehensive new national survey...
AMMAN – The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, has concluded the...
In a sobering turn of events for the biotechnology sector, Caribou Biosciences—a company anchored by the prestige...
In a significant move that promises to reshape the landscape of urological care, Zenflow, a California-based medical...
In the landscape of modern drug discovery, a profound transformation is underway. What was once a static,...
In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...
Introduction: A New Perspective on Auditory Decline Age-related hearing loss, often dismissed as an inevitable consequence of...
